Urine prothrombin fragments (F1+2) as a diagnostic tool for arterial and venous thrombosis

Urine prothrombin fragments (F1+2) as a diagnostic tool for arterial and venous thrombosis - The UPF study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON34836

Enrollment

Registered

2010-06-18

Start date

2010-04-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bloedstolling, veneuze trombo embolien arterial and venous thrombosus deep vein thrombosus myocardial infarction pulmonary embolism thrombosus

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Males and females, aged 18 years and older with an objectively confirmed venous thrombo-embolism, either DVT or PE (by means of ultrasonography, computerized tomography or ventilation perfusion scanning) and an objectively confirmed diagnosis of myocardial infarction (by means of elevated cardiac enzymes or abnormal elecocardiogram.

Exclusion criteria

Exclusion criteria: Since this is a pilot study, there are no exclusion criteria.

Design outcomes

Primary

Measure	Time frame
Urine F1+2 levels	—

Secondary

Measure	Time frame
Increased levels of urine F1+2 coincide with increased plasma levels of ddimer and F1+2 in case of VTE and troponine T, CKMB, d-dimer and F1+2 in plasma samples in patients with MI.	—

Countries

Netherlands

Outcome results